Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been given an average recommendation of “Buy” by the sixteen analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $56.91.
A number of equities research analysts recently weighed in on ACHC shares. Jefferies Group LLC set a $60.00 target price on Acadia Healthcare and gave the stock a “buy” rating in a research report on Wednesday, October 11th. Deutsche Bank AG lifted their target price on Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a research report on Monday, July 31st. Craig Hallum reissued a “buy” rating and set a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Mizuho lifted their target price on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. Finally, BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 1st.
Shares of Acadia Healthcare (ACHC) traded up 0.60% during mid-day trading on Thursday, reaching $41.81. The company’s stock had a trading volume of 927,545 shares. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.34. The company has a 50 day moving average price of $46.12 and a 200 day moving average price of $46.36. The stock has a market capitalization of $3.67 billion, a P/E ratio of 459.45 and a beta of 1.07.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The business had revenue of $715.90 million for the quarter, compared to the consensus estimate of $717.38 million. During the same period last year, the business earned $0.73 earnings per share. The firm’s revenue for the quarter was down 5.4% compared to the same quarter last year. On average, equities research analysts anticipate that Acadia Healthcare will post $2.44 earnings per share for the current fiscal year.
In other news, President Brent Turner sold 206,252 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $10,454,913.88. Following the completion of the transaction, the president now owns 81,106 shares in the company, valued at $4,111,263.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Reeve B. Waud sold 1,240,000 shares of Acadia Healthcare stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $51.72, for a total transaction of $64,132,800.00. The disclosure for this sale can be found here. Insiders have sold 3,085,693 shares of company stock worth $157,729,099 over the last ninety days. Company insiders own 11.10% of the company’s stock.
Large investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Acadia Healthcare by 11.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after acquiring an additional 270 shares during the last quarter. C M Bidwell & Associates Ltd. bought a new position in shares of Acadia Healthcare in the second quarter valued at approximately $205,000. Riverhead Capital Management LLC bought a new position in shares of Acadia Healthcare in the second quarter valued at approximately $209,000. World Asset Management Inc bought a new position in shares of Acadia Healthcare in the second quarter valued at approximately $242,000. Finally, Paloma Partners Management Co bought a new position in shares of Acadia Healthcare in the first quarter valued at approximately $217,000.
ILLEGAL ACTIVITY WARNING: “Acadia Healthcare Company, Inc. (ACHC) Receives Consensus Recommendation of “Buy” from Brokerages” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2017/10/26/acadia-healthcare-company-inc-achc-receives-consensus-recommendation-of-buy-from-brokerages.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.